Exhibit 1
JOINT FILING STATEMENT
I, the undersigned, hereby express my agreement that the attached Amendment No. 3 to Schedule 13D (and any amendments thereto) relating to the common stock of Pharmathene, Inc. is filed on behalf of each of the undersigned.
Dated: February11, 2016
| MPM BIOVENTURES III, L.P. | MPM BIOVENTURES III-QP, L.P. | |||||||
| By: | MPM BioVentures III GP, L.P., its General Partner |
By: | MPM BioVentures III GP, L.P., its General Partner | |||||
| By: | MPM BioVentures III LLC, its General Partner |
By: | MPM BioVentures III LLC, its General Partner | |||||
| By: | /s/ Luke Evnin |
By: | /s/ Luke Evnin | |||||
| Name: Luke Evnin | Name: Luke Evnin | |||||||
| Title: Series A Member | Title: Series A Member | |||||||
| MPM BIOVENTURES III PARALLEL FUND, L.P. | MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG | |||||||
| By: | MPM BioVentures III GP, L.P., its General Partner |
By: | MPM BioVentures III GP, L.P., in its capacity as the Managing Limited Partner | |||||
| By: | MPM BioVentures III LLC, its General Partner |
By: | MPM BioVentures III LLC, its General Partner | |||||
| By: | /s/ Luke Evnin |
By: | /s/ Luke Evnin | |||||
| Name: Luke Evnin | Name: Luke Evnin | |||||||
| Title: Series A Member | Title: Series A Member | |||||||
| MPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLC | MPM BIOVENTURES III GP, L.P. | |||||||
| By: | MPM BioVentures III LLC, its General Partner | |||||||
| By: | /s/ Luke Evnin |
|||||||
| Name: Luke Evnin | ||||||||
| Title: Manager | By: | /s/ Luke Evnin | ||||||
| Name: Luke Evnin | ||||||||
| Title: Series A Member | ||||||||
| MPM BIOVENTURES III LLC | ||||||||
| By: | /s/ Luke Evnin |
/s/ Luke Evnin | ||||||
| Name: Luke Evnin | Luke Evnin | |||||||
| Title: Series A Member | ||||||||
| /s/ Ansbert Gadicke Ansbert Gadicke |
/s/ Nicholas Galakatos Nicholas Galakatos | |||
| /s/ Michael Steinmetz Michael Steinmetz |
/s/ Kurt Wheeler Kurt Wheeler | |||
| /s/ Nicholas Simon III Nicholas Simon III |
/s/ Dennis Henner Dennis Henner | |||
Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).